Publication Name	World Journal of Hepatology
Manuscript ID	99999
Country	China

Received	2024-08-05 07:19
Peer-Review Started	2024-08-05 07:19
To Make the First Decision
Return for Revision	2024-09-18 03:21
Revised	2024-09-30 11:43
Second Decision	2024-10-15 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-15 08:14
Articles in Press	2024-10-15 08:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-23 01:10
Publish the Manuscript Online	2024-11-06 09:50

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Letter to the Editor
Article Title	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action
Manuscript Source	Invited Manuscript
All Author List	Lei Ma and Hui-Chun Xing
ORCID	Author(s) ORCID Number Hui-Chun Xing http://orcid.org/0000-0002-9111-9669
Funding Agency and Grant Number	Funding Agency Grant Number National Key Research and Development Program of China No. 2022YFC2304505 National Key Research and Development Program of China No. 2021YFC2301801 Beijing Municipal of Science and Technology Major Project No. 20220383ky Capital’s Funds for Health Improvement and Research of China No. 2024-1-2181
Corresponding Author	Hui-Chun Xing, MD, Professor, Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China. huichunxing@126.com
Key Words	Hepatitis B virus; Chronic hepatitis B; Cirrhosis; Treatment; Diagnosis
Core Tip	Currently, the rates of diagnosis and treatment are significantly low, particularly in resource-limited developing countries. Therefore, immediate action must be taken without any delay. In the expanding screening population, it is essential to prioritize hepatitis B surface antigen testing for all high-risk groups and utilize high sensitivity hepatitis B virus DNA testing to detect low-level viremia, which is associated with the prognosis of hepatitis B virus infection. Some patients in the indeterminate phase require immediate antiviral treatment. Reducing the cost and improving access to screening and treatment are also crucial, highlighting the need for collaboration between governments, healthcare organizations, and pharmaceutical companies. Integrating the delivery of care, prevention, and treatment for hepatitis B into existing health services can streamline testing, care, and treatment for hepatitis B.
Publish Date	2024-11-06 09:50
Citation	<p>Ma L, Xing HC. Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action. <i>World J Hepatol</i> 2024; 16(11): 1361-1364</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i11/1361.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i11.1361

Full Article (PDF)	WJH-16-1361-with-cover.pdf
Manuscript File	99999_Auto_Edited_021931.docx
Answering Reviewers	99999-answering-reviewers.pdf
Audio Core Tip	99999-audio.mp3
Conflict-of-Interest Disclosure Form	99999-conflict-of-interest-statement.pdf
Copyright License Agreement	99999-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	99999-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	99999-non-native-speakers.pdf
Peer-review Report	99999-peer-reviews.pdf
Scientific Misconduct Check	99999-scientific-misconduct-check.png
Scientific Editor Work List	99999-scientific-editor-work-list.pdf
CrossCheck Report	99999-crosscheck-report.png
CrossCheck Report	99999-crosscheck-report.pdf